Eurobio Scientific reported €84.5 million in first-half 2026 revenue, up 4.5% year over year, with net income nearly doubling to €4.7 million. The company completed acquisition of CareDx's Lab Solutions business, strengthening its transplantation diagnostics portfolio with the AlloSeq product
News
Diagnostics
Innovation
Research
The Research category covers the latest medical studies, breakthroughs, and scientific advancements shaping the future of healthcare.

